Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04057638
Other study ID # s19-00621
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 17, 2019
Est. completion date January 1, 2026

Study information

Verified date March 2024
Source NYU Langone Health
Contact Thomas Calahan, BA
Phone (929) 455-5826
Email Thomas.Calahan@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate functional and aesthetic outcomes of combined facial and upper extremity composite tissue allografts on patients who have not achieved functional and aesthetic outcomes with conventional reconstructive surgical strategies and prosthetic devices.


Description:

The purpose of this study is to see if an investigational surgery that transfers tissue from a non-living donor to a living individual will help restore greater function, appearance, and sensation to the face and upper extremity areas of individuals who have suffered injury to those areas. Upper extremity constitutes the part of the body including arm, forearm and hand. This procedure is called combined craniomaxillofacial and upper extremity allotransplantation or "combined face and upper extremity transplant". This study will also collect data on how patients do during and after having a combined face and upper extremity transplant from a nonliving donor. Recovery and outcomes will be observed through clinical exams, x-rays, blood and tissue tests, and other associated evaluations at all follow up visits. Participants are invited to take part in this research study who have suffered severe injury to the face and upper extremity and previous surgeries to repair the injury have not restored function, appearance, and sensation. Participants must have attempted a trial of prosthetics (artificial upper extremity), if at all possible.


Recruitment information / eligibility

Status Recruiting
Enrollment 10
Est. completion date January 1, 2026
Est. primary completion date January 1, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 64 Years
Eligibility Inclusion Criteria: - Signed and dated all required Institutional Review Board (IRB) approved consent forms. - Male or female recipient between the ages of 18-64 years. Recipients do not need to be of the same sex as the donor. - Facial composite tissue defect requiring facial transplantation as determined by the treating Plastic and Reconstructive Surgeon. Inclusive facial functional subunit tissue loss. Including but not limited to irreparable peri-oral, peri-orbital, and peri-nasal damage. - Missing part of one or both hands and forearms. - Must be HIV negative at the time of transplant. - Crossmatch is negative at the time of transplant. - Patient has been encouraged to seek a second opinion from a Plastic Surgeon with specialized focus in facial reconstruction. - Patient has been encouraged to seek a second opinion from a Plastic Surgeon with specialized focus in upper extremity reconstruction. - Willingness to participate in ongoing psychiatric, psychological and social work evaluations prior to and post-transplant surgery. - The subject is able to complete pre-transplant examination and screening procedures. - Patient has been approved by Patient Selection Committee for placement on the recipient waiting list. - The subject is willing to continue immunosuppression regimen as directed by treating physician. - Subject is willing and able to return to follow-up visits as described in treatment plan. - Subjects must have autogenous tissue options available for reconstruction in event of graft failure. - Normal glomerular filtration rate (GFR) >60. - Negative pregnancy test within 48hrs of transplant for women of childbearing age and who agree to use a reliable form of contraception for one year following transplant. Exclusion Criteria: - Uncontrolled infection or severe concomitant diseases which would exclude the recipient from transplantation - Serious co-morbidities - Positive serology for HIV; Hepatitis B Antigen - Active malignancy within 5 years with the exclusion of non-melanoma - Substance abuse disorders not currently under control (as determined by the Michigan Alcohol Screening Test - see Appendix N.1: Subjects with a score of 3 or more will be excluded) - Body Dysmorphic disorder (see Appendix N.2 for screening tool). Less severe psychiatric conditions are addressed on a case by case basis - Active Severe Psychiatric Illness - Cognitive limitations affecting the patient's ability to provide informed consent - Recent history of medical non-adherence - Unstable social situation as evidence by lack of stable housing and/or lack of a supportive significant other. - Recent history of medical non-adherence. - Lack of stable housing and/or supportive significant other/caregiver throughout all phases of the study - Currently active smoker within 1 year - Subjects with any cognitive deficits related to a traumatic brain injury (TBI) and or any organic neurological disorders - Any other psychological status that would hinder the success or safety of the transplantation. - Level of amputation proximal to mid-humerus: some presence of proximal muscles is required to motor a functioning hand. - Congenital Abnormalities: co-existent absence/atrophy/agenesis of any tissue may affect post-transplant results - History of amputation of less than six months: subject must be allowed to attempt prosthetic use prior to hand transplantation. This can be waived in cases where the recipient requires amputation/revision of the transplant site at the time of transplantation. However, if at all possible, it is highly encouraged that the patient has ruled out prosthetics as an alternative to transplantation. - Blindness: blind amputees may be poor candidates because sensory return in the hand may not provide sufficient protective sensation - Pregnancy

Study Design


Intervention

Procedure:
Combined Craniomaxillofacial and Upper Extremity Allotransplantation
Combined Craniomaxillofacial and Upper Extremity Allotransplantation

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in function of the transplanted facial segment This will be measured using electromyogram (EMG) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the transplanted facial segment This will be measured using nerve conduction studies (NCS) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the transplanted facial segment This will be measured using computerized tomography angiogram (CTA) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the transplanted facial segment This will be measured using magnetic resonance imaging (MRI) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the transplanted facial segment This will be measured using vision exams Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the upper extremity transplant This will be measured using pathology samples to check for rejection Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the upper extremity transplant This will be measured using electromyogram (EMG) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the upper extremity transplant This will be measured using nerve conduction studies (NCS) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the upper extremity transplant This will be measured using computerized tomography angiogram (CTA) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in function of the upper extremity transplant This will be measured using magnetic resonance imaging (MRI) Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in appearance of the transplanted facial segment This will be measured using photography Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
Primary Change in appearance of the upper extremity transplant This will be measured using photography Monthly for 6 months, every 6 months for 2 years, then annually up to year 5
See also
  Status Clinical Trial Phase
Recruiting NCT05846399 - CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE) Phase 4
Not yet recruiting NCT05060900 - Hand Ligament Reconstructions With Knee Collateral Ligament Allografts N/A
Withdrawn NCT04291170 - Comparison of Upper Extremity and Lower Extremity Function and Quick DASH N/A
Active, not recruiting NCT05280704 - Traditional Dorsal Digital Block vs Volar Subcutaneous Digital Block N/A
Not yet recruiting NCT05003596 - Efficacy of Steroids on Functional Outcomes After Musculoskeletal Injuries of the Hand Phase 2/Phase 3
Not yet recruiting NCT03937232 - Mirrored Movement Compared to Cross-education N/A
Completed NCT04068506 - Analgesic Effects of Gabapentin and Paracetamol Phase 4
Completed NCT04328623 - Interest of Hypnosis on Pain Management During a Guided Echo Infiltration of the Hand N/A
Recruiting NCT04895891 - 3D Personalized Modelization of the Hand Using EOS Imaging System N/A
Completed NCT01210833 - Using HandTutor With Traumatic Hand Injuries: Characterizing the System N/A
Recruiting NCT06086392 - Perineural Dexamethasone in Supraclavicular Brachial Plexus Block for Anesthesia After Pediatric Hand/Wrist Surgery Phase 4
Completed NCT05878509 - Reliability and Validity of the Tampa Scale for Kinesiophobia
Withdrawn NCT04027569 - PROMs To Improve Care- Standardized vs Patient Specific N/A
Completed NCT03345693 - Use of MoTrack Therapy in At-Home Hand Rehabilitation N/A
Completed NCT06112145 - Are Rehabilitation Results in Flexor Tendon Zone II Injuries as Bad as Feared? N/A
Completed NCT03496337 - Is AMPS a Responsive Tool for Assessing Change in ADL-abilities After Finger or Hand Surgery
Completed NCT02789852 - Evaluation of the Effectiveness of Night Orthosis in Treating Women With Symptomatic Osteoarthritis in the Interphalangeal Joint of the Dominant Hand N/A
Completed NCT02331004 - Effectiveness of an Intervention Program for Fine Motor Skills N/A
Completed NCT04486053 - Long-term Results of Pediatric Flexor Tendon Injuries
Completed NCT03458013 - Psychosocial Outcomes in Hand Therapy N/A